Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002603 stock hub

SHE/002603 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002603is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

29B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002603

In the news

Latest news · SHE/002603

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.3

P25 17.1P50 24.2P75 37.8

Trailing P/E21.1

P25 23.5P50 41.3P75 83.2

ROE12.5

P25 -0.9P50 4.1P75 8.8

ROIC15

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002603 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

CNY

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	11,343
Employees Change	-365%
Employees Change Percent	-3.12
Enterprise value	CNY 26.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000015S0
Last refreshed	2026-05-10
Market cap	CNY 29B
Price	CNY 17.33
Price currency	CNY
Rev Per Employee	697,548.14x
Sector	Healthcare
Sic	2834
Symbol	she/002603
Website	https://www.yiling.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.73%
EV Earnings	19.38x
EV/EBIT	15.81x
EV/EBITDA	11.5x
EV/FCF	14.86x
EV/Sales	3.35x
FCF yield	6.17%
Forward P/E	19.26x
P/B ratio	2.54x
P/E ratio	21.14x
P/S ratio	3.66x
PE Ratio10 Y	35.39x
PE Ratio3 Y	58.74x
PE Ratio5 Y	42.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.22%
EBITDA Margin	29.04%
FCF margin	22.57%
Gross margin	65.12%
Gross Profit	CNY 5.2B
Gross Profit Growth	71.9%
Gross Profit Growth Q	15.44%
Gross Profit Growth3 Y	-16.57%
Gross Profit Growth5 Y	-4.54%
Net Income	CNY 1.4B
Net Income Growth Q	25.43%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Net Income Growth3 Y	-23.68%
Net Income Growth5 Y	-1.21%
Pretax Margin	21.32%
Profit Margin	17.31%
Profit Per Employee	CNY 120,724
Profitable Years	1
ROA	7.53
Roa5y	6
ROCE	14.15
ROE	12.47
Roe5y	11.16
ROIC	15.01
Roic5y	11.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.51%
Cagr1y	27.52%
Cagr3y	-16.89%
Cagr5y	0.3%
Div CAGR10	15.43%
Div CAGR3	-15.66%
Div CAGR5	-21.4%
EPS Growth Q	25.42
EPS Growth Quarters	5
EPS Growth Years	1
EPS Growth3 Y	-23.68
EPS Growth5 Y	-1.17
FCF Growth	214.53%
FCF Growth Q	84.65%
FCF Growth3 Y	-16.68%
OCF Growth	145.43%
OCF Growth Q	79.57%
OCF Growth10 Y	27.46%
OCF Growth3 Y	-15.08%
OCF Growth5 Y	62.83%
Revenue Growth	24.64x
Revenue Growth Q	3.46x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-16.82x
Revenue Growth5 Y	-4.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.57
Assets	CNY 14.2B
Cash	CNY 2.4B
Current Assets	CNY 5.8B
Current Liabilities	CNY 2.3B
Debt	CNY 23.4M
Debt EBITDA	CNY 0.01
Debt Equity	CNY 0
Debt FCF	CNY 0.01
Equity	CNY 11.4B
Interest Coverage	1,306.6
Liabilities	CNY 2.8B
Long Term Assets	CNY 8.4B
Long Term Liabilities	CNY 474.6M
Net Cash	CNY 2.4B
Net Cash By Market Cap	CNY 8.31
Net Cash Growth	111.16%
Net Debt EBITDA	CNY -1.05
Net Debt Equity	CNY -0.21
Net Debt FCF	CNY -1.35
Tangible Book Value	CNY 10.5B
Tangible Book Value Per Share	CNY 6.29
WACC	7.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.5
Inventory Turnover	2.02
Net Working Capital	CNY 1.1B
Quick ratio	1.87
Working Capital	CNY 3.5B
Working Capital Turnover	CNY 2.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.02%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 1
Dividend Years	14
Dividend Yield	5.77%
Ex Div Date	2025-10-22
Last Dividend	CNY 0.3
Payout Frequency	Annual
Payout Ratio	36.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	87.93%
1Y total return	27.5%
200-day SMA	17.11
3Y total return	-42.59%
50-day SMA	16.8
50-day SMA vs 200-day SMA	50under200
5Y total return	1.49%
All Time High	53.96
All Time High Change	-67.88%
All Time High Date	2022-12-08
All Time Low	7.08
All Time Low Change	144.81%
All Time Low Date	2018-10-19
ATR	0.39
Beta	0.52
Beta1y	0.29
Beta2y	0.52
Ch YTD	1.52
High	17.48
High52	21.58
High52 Date	2025-11-14
High52ch	-19.69%
Low	17.13
Low52	13.76
Low52 Date	2025-05-08
Low52ch	26.04%
Ma50ch	3.14%
Price vs 200-day SMA	1.28%
RSI	60.04
RSI Monthly	49.06
RSI Weekly	52.22
Sharpe ratio	0.98x
Sortino ratio	1.81
Total Return	5.75%
Tr YTD	1.52
Tr1m	3.34%
Tr1w	1.46%
Tr3m	-4.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 1.7B
Operating Income Growth Q	17.64
Operating Income Growth3 Y	-23.34
Operating Income Growth5 Y	-0.61
Operating margin	21.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	723,332,865%
Net Borrowing	-12,308,548
Shares Insiders	25.17%
Shares Institutions	4.85%
Shares Out	1,670,705,376
Shares Qo Q	-0.01%
Shares Yo Y	0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 1.8B
Average Volume	16,582,261.55x
Bv Per Share	6.82
CAPEX	CNY -261.1M
Ch10y	63.49
Ch1m	3.34
Ch1w	1.46
Ch1y	25.31
Ch3m	-4.15
Ch3y	-45.74
Ch5y	-8.48
Ch6m	-7.43
Change	1.05%
Change From Open	0.58
Close	17.15
Days Gap	0.47
Depreciation Amortization	618,315,470
Dollar Volume	360,165,282.8
Earnings Date	2026-04-28
EBIT	CNY 1.7B
EBITDA	CNY 2.3B
EPS	CNY 0.82
F Score	7
FCF	CNY 1.8B
FCF EV Yield	6.73x
FCF Per Share	CNY 1.07
Financing CF	-515,659,714
Fiscal Year End	December
Founded	1,992
Goodwill	101,716,533
Graham Number	11.21665
Graham Upside	-35.28
Income Tax	CNY 320.4M
Investing CF	-1,733,098,315
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2021-07-07
Last Split Type	Forward
Lynch Fair Value	CNY 4.1
Lynch Upside	-76.35
Ma150	17.43
Ma150ch	-0.56%
Ma20	16.81
Ma20ch	3.09%
Net CF	-202,256,432
Next Earnings Date	2026-08-28
Open	17.23
P FCF Ratio	16.21
P OCF Ratio	14.14
Payment Date	2025-10-22
Position In Range	57.14
Ppne	6,850,088,522
Price Date	2026-05-08
Price EBITDA	CNY 12.6
Ptbv Ratio	2.75
Relative Volume	1.29x
Revenue	7,912,288,563x
Tax By Revenue	4.05x
Tax Rate	19%
Tr6m	-7.43%
Volume	20,782,763
Z Score	7.85

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002603 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.8%

$1.00 annual per share

Payout ratio

+36.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-21.4%

0 consecutive years of growth

Total shareholder yield

+5.8%

Next ex-dividend date: 2025-10-22

Performance

SHE/002603 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002603?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.8%

Share of float held by funds and institutions

Insider ownership

+25.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

SHE/002603 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.0

Neutral momentum band

Price vs 200-day MA

+1.3%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

0.98

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002603

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002603 stock rating?

she/002603 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002603 analysis?

The full report lives at /stocks/she/002603/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002603?

The latest report frames she/002603 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002603 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.